Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Free Cash Flow (2016 - 2026)

Avanos Medical's Free Cash Flow history spans 13 years, with the latest figure at $21.3 million for Q4 2025.

  • On a quarterly basis, Free Cash Flow fell 67.38% to $21.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $43.1 million, a 54.68% decrease, with the full-year FY2025 number at $43.1 million, down 54.68% from a year prior.
  • Free Cash Flow hit $21.3 million in Q4 2025 for Avanos Medical, up from $7.0 million in the prior quarter.
  • Over the last five years, Free Cash Flow for AVNS hit a ceiling of $65.3 million in Q4 2024 and a floor of -$12.1 million in Q1 2024.
  • Historically, Free Cash Flow has averaged $16.8 million across 5 years, with a median of $19.5 million in 2024.
  • Biggest five-year swings in Free Cash Flow: skyrocketed 1068.42% in 2021 and later plummeted 237.5% in 2023.
  • Tracing AVNS's Free Cash Flow over 5 years: stood at $62.8 million in 2021, then dropped by 29.62% to $44.2 million in 2022, then crashed by 52.04% to $21.2 million in 2023, then surged by 208.02% to $65.3 million in 2024, then tumbled by 67.38% to $21.3 million in 2025.
  • Business Quant data shows Free Cash Flow for AVNS at $21.3 million in Q4 2025, $7.0 million in Q3 2025, and -$4.2 million in Q2 2025.